Skip to main content
. 2020 Nov 13;10:587692. doi: 10.3389/fonc.2020.587692

Table 5.

Adverse events of 46 patients treated with fruquintinib.

Adverse events Any grade Grade ≥3
Non-hematologic
 Hypertension 13 (28.3) 3 (6.5)
  Hand-foot syndrome 17 (37.0) 6 (13.0)
  Proteinuria 3 (6.5) 0 (0.0)
  Hepatotoxicity 15 (32.6) 2 (4.3)
  Fatigue 12 (26.1) 1 (2.2)
  Bleeding 2 (4.3) 0 (0.0)
  Diarrhea 6 (13.0) 0 (0.0)
Hematologic
 Leukopenia 6 (13.0) 2 (4.3)
 Neutropenia 5 (10.9) 1 (2.2)
  Thrombocytopenia 11 (23.9) 4 (8.7)
  Anemia 18 (39.1) 2 (4.3)